Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neta Zach

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Trials (London, England)|July 2, 2019
Design and analysis of a clinical trial using previous trials as historical controlDavid Alan Schoenfeld, Dianne M Finkelstein, Eric Macklin, et al.
Neuromuscular Disorders : NMD|March 5, 2023
Urine titin as a novel biomarker for Duchenne muscular dystrophyMisawa Niki Ishii, Masato Nakashima, Hidenori Kamiguchi, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Predicting disease progression in amyotrophic lateral sclerosisAlbert A Taylor, Christina Fournier, Meraida Polak, et al.
Health and Quality of Life Outcomes|January 22, 2022
Qualitative measures that assess functional disability and quality of life in ALSSusan L Hartmaier, Thomas Rhodes, Suzanne F Cook, et al.
Skeletal Muscle|November 19, 2023
Electrical impedance myography detects dystrophin-related muscle changes in mdx miceTetsuaki Hiyoshi, Fuqiang Zhao, Rina Baba, et al.
Neurology|October 10, 2014
The PRO-ACT database: design, initial analyses, and predictive featuresNazem Atassi, James Berry, Amy Shui, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Molecular Neurobiology|October 19, 2018
Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington DiseaseMarta Garcia-Miralles, Nur Amirah Binte Mohammad Yusof, Jing Ying Tan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 21, 2021
ALSUntangled 59: TamoxifenRichard Bedlack, Sky Kihuwa-Mani, Paul E Barkhaus, et al.
Nature Biotechnology|November 3, 2014
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progressionRobert Küffner, Neta Zach, Raquel Norel, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Trials (London, England)|July 2, 2019
Design and analysis of a clinical trial using previous trials as historical controlDavid Alan Schoenfeld, Dianne M Finkelstein, Eric Macklin, et al.
Neuromuscular Disorders : NMD|March 5, 2023
Urine titin as a novel biomarker for Duchenne muscular dystrophyMisawa Niki Ishii, Masato Nakashima, Hidenori Kamiguchi, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Predicting disease progression in amyotrophic lateral sclerosisAlbert A Taylor, Christina Fournier, Meraida Polak, et al.
Health and Quality of Life Outcomes|January 22, 2022
Qualitative measures that assess functional disability and quality of life in ALSSusan L Hartmaier, Thomas Rhodes, Suzanne F Cook, et al.
Skeletal Muscle|November 19, 2023
Electrical impedance myography detects dystrophin-related muscle changes in mdx miceTetsuaki Hiyoshi, Fuqiang Zhao, Rina Baba, et al.
Neurology|October 10, 2014
The PRO-ACT database: design, initial analyses, and predictive featuresNazem Atassi, James Berry, Amy Shui, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Molecular Neurobiology|October 19, 2018
Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington DiseaseMarta Garcia-Miralles, Nur Amirah Binte Mohammad Yusof, Jing Ying Tan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 21, 2021
ALSUntangled 59: TamoxifenRichard Bedlack, Sky Kihuwa-Mani, Paul E Barkhaus, et al.
Nature Biotechnology|November 3, 2014
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progressionRobert Küffner, Neta Zach, Raquel Norel, et al.
Pageof 3